A/Professor Christopher McIntyre
Conflicts of interest include consultancy work for Gambro, Braun, Sanofi, Ardelyx. Grant funding Baxter, Reatta, Gambro.
Professor Jean-Paul Soulillou
Conflicts as co founder of TcLand expression and Effimune, two Biotech companies , my research activities receive also support from Fujisawa and Novartis.
LINAGLIPTIN REDUCES HIGH GLUCOSE INDUCED INFLAMMATORY AND FIBROTIC MARKERS IN HUMAN KIDNEY PROXIMAL TUBULAR CELLS
Panchapakesan U, Komala M, Mather A, Pegg K, Gross S, Pollock C
Boehringer Ingelheim provided the linagliptin and financial support.